This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Carlstedt, B. C. Search for Related Content Social Bookmarking                         What's this?

Pharmacotherapy of Asthma

The approach to asthma therapy has changed from an emphasis on bronchodilation to an emphasis on anti-inflammatory medications. New guidelines from the National Asthma Education and Prevention Program Expert Panel II were released in February 1997 and emphasize that inhaled corticosteroids are the cornerstone of pharmacotherapy. New inhaled corticosteroids and new delivery methods have been introduced which have significant advantages over older products. Pharmacological innovations such as the leukotriene modifiers represent continued research to influence the inflammatory response. Agents or therapies which can decrease the daily dose of systemic corticosteroids continue to be investigated in continued efforts to reduce the side effects and adverse reactions associated with systemic corticosteroid therapy.

Journal of Pharmacy Practice, Vol. 10, No. 3, 147-164 (1997)
DOI: 10.1177/089719009701000306


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?